News
1 Supercharged Growth Stock That's a Shoo-in to Join Apple and Microsoft in the $2 Trillion Club by 2028
On the heels of the worst stock market performance in more than 10 years, technology stocks have bounced back, with the Nasdaq Composite up 29% so far this year. This recovery seems poised to add
4 Top Dividend Payers of the S&P 500
Imagine you had invested $1,000 in the S&P 500-tracking SPDR S&P 500 ETF Trust when it launched in January 1993. As of Aug. 21, 2023, if you had spent your dividends along the way, your investment
3 Top Growth Stocks to Buy Before the Next Bull Market
In this video, I will talk about three interesting companies that are worth your attention, especially during these uncertain times. I chose a mix of companies in different industries that could
Amid Slowing Growth, Apple's Ace in the Hole Is More Important Than Ever
Everyone knows Apple (NASDAQ: AAPL) for its iconic brand. But investors know Apple as a long-term outperforming stock and the largest U.S.-based company by market cap.
Apple uses a lot of its excess
Could This Medicine Be the Next Winner for Novartis?
Earlier this month, the Switzerland-based pharmaceutical Novartis (NYSE: NVS) shared encouraging news from two phase 3 clinical trials of its drug candidate remibrutinib for a skin condition known
1 Reason Carvana Stock Is a Screaming Buy, and 1 Reason to Avoid It Like the Plague
After tanking 98% in 2022, Carvana (NYSE: CVNA) shares are bouncing back nicely this year. They have soared a whopping 752% in 2023 (as of Aug. 21), a clear sign of renewed optimism from investors.
Why VinFast Auto Stock Swung Wildly Today After Doubling Yesterday
After skyrocketing by more than 108% yesterday, shares of VinFast Auto (NASDAQ: VFS) are highly volatile after initially plunging back to earth today. The stock dropped 19% in early Wednesday
2 Top Stocks Billionaires Can't Stop Buying in This Bear Market
Although there are some indications that we've left the bear market behind, we'll know for sure when the market exceeds its previous high. That came very close to happening toward the end of July
3 Stocks With High Dividend Yields
Many companies have put a lower priority on paying dividends over the years. The average dividend yield of stocks in the S&P 500 has fallen from over 3% a few decades ago to less than 2% in the past
A Bull Market Is Coming: 2 Beaten-Down Growth Stocks With 135% and 121% Upside, According to Wall Street
The technical definition of a bear market is clear. Once a benchmark index like the S&P 500 falls by 20% from its all-time high, it's considered to be in bear territory. Declaring the start of a new
2 Hot IPO Stocks That Could Crush the Market
The initial public offering (IPO) market has been mostly quiet over the past year after a record amount of IPOs in 2021, a special purpose acquisition company (SPAC) bust last year, and a bear
Are Walmart's Profits Poised to Surge With Online Growth and Consumer Staples?
Walmart (NYSE: WMT) has showcased its leadership in the world of consumer spending yet again in its most recent results. The retail behemoth's second-quarter earnings report reveals a remarkable
Investors Are Giving Up on These 2 Stocks -- Should You?
There's been considerable uncertainty in the stock investing community lately. After a strong start to 2023, stock prices have gotten choppy in the summer months, and that has put many investors on
Got $5,000? Invest in These 2 Unstoppable Growth Stocks.
Now might be a difficult time to invest a lot of money in stocks. A challenging economy limits how much investors have to put into the market, which means it's important to be more selective in
Better Buy: Disney vs. Target
Investing in the best stocks involves choosing ones with the best long-term prospects. While this sounds simple, executing this plan can prove challenging. After all, no one has a functional crystal
3 Fast-Food Chain Stocks Growing by More Than 10% This Year -- But Only One Is a No-Brainer Buy
Fast-food restaurants have proven to be relatively resilient amid inflation. Even as costs and wages have gone up, popular chains have been able to raise prices and generate positive year-over-year
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
More than three years after deeming COVID-19 a global health emergency, the World Health Organization ended the pandemic's special status in May.
This was certainly welcome news for numerous
Is This Nvidia's Newest Money-Making Machine?
In today's video, I discuss Nvidia (NASDAQ: NVDA), recent thoughts about its L40S GPUs, and recent updates to its VMware (NYSE: VMW) partnership. Check out the short video to learn more, consider
EQS-News: Steinhoff International Holdings N.V. in liquidatie: SHAREHOLDER CVR RECORD DATE AND REGISTRATION
2 Reasons to Buy Amazon Stock Before It's Too Late
Up by a whopping 55% year to date, Amazon's (NASDAQ: AMZN) stock is finally beginning to shake off the post-pandemic slump it endured for most of last year. While the company still faces some
Where Will Microsoft Stock Be in 3 Years?
Microsoft (NASDAQ: MSFT) stock might not show up on many investors' radars today given its rally so far in 2023. The tech giant has gained over 30% this year, more than doubling the rally in the S&P
Up 200%, Is Nvidia Stock Still a Buy?
Nvidia (NASDAQ: NVDA) has been one of 2023's best-performing tech companies, with shares up by more than 200% year to date. That rally, which lifted it to mega-cap status, was largely driven by
1 Monster Metaverse Stock to Buy for the Long Haul
While excitement around artificial intelligence has gone through the roof in 2023, investors shouldn't forget other potential innovations that could still present them with opportunities.
The metave
The Leading Investment for Cutting-Edge Generative AI Right Now -- and No, It's Not Microsoft
Artificial intelligence (AI) is transforming the world in unprecedented ways. AI enhances our lives and creates new possibilities, from self-driving cars to smart assistants. But how can investors
These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street
Unprofitable clinical-stage biotechs have lost their appeal in the past year, given the challenging economic and market conditions we still haven't entirely left behind. That's why companies such as